Impact on Quality of Life of Osteopathic Visceral Mobilizations After Endometriosis Surgery
Condition(s) studied
Investigational drug(s) / intervention(s)
osteopatic visceral mobilization: a combination of breathing and visceral mobilizations
Study summary
One of the most common post-operative complications of gynaecological surgery, and in particular endometriosis surgery, is the formation of peritoneal adhesions. After laparotomy, it affects up to 90% of patients. Minimally invasive techniques (such as laparoscopy) reduce the risk of adhesion formation, but cannot totally prevent it. Adhesions can lead to chronic pelvic pain, dyspareunia, digestive disorders and infertility. Various strategies and devices have been developed to try and limit adhesion formation, but their effectiveness has not been fully proven in the literature. The only real treatment for adhesions is adhesiolysis, although adhesions often reform. The quality of surgery remains the best means of preventing adhesion formation. To reduce the morbidity associated with pelvic adhesions, it is essential to develop alternative, non-invasive, anti-adhesive methods such as manual osteopathic visceral mobilization.
Eligibility
Primary outcome measure(s)
- Quality of life with the EHP-30 questionnaire score — 1 year
Percentage change in baseline questionnaire score (EHP-30) between pre-operative visit and 1 year. The EHP-30 contains 30 items and ranges from 0 (best health) to 100 (worst health). The items in the baseline questionnaire are grouped into 5 main sub-domains: pain, control and powerlessness, emotional well-being, social support and self-image.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| CHU de Clermont-Ferrand | Clermont-Ferrand | France | Recruiting |
More University Hospital, Clermont-Ferrand trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06553989 on ClinicalTrials.gov ↗ ← All trials in France